Combined therapy shows promise for chronic lymphocytic leukemia
Male fertility is declining, environmental toxins could be a reason
2 August 2021Social determinants recorded in only 0.2% of mental health contact cases
2 August 2021Combined therapy shows promise for chronic lymphocytic leukemia
A combination therapy pairing a small molecule inhibitor with monoclonal antibody immunotherapy improved patient outcomes for relapsed chronic lymphocytic leukemia (CLL), according to a Northwestern Medicine clinical trial published in Blood.
